Daily Market Briefing

2026-10-25 · Money Checkup market briefing

# Broad Selloff Masks Dramatic Moves in Biotech Equipment and Precious Metals

The major indices posted modest declines on October 25, with the S&P 500 down 0.52% and the Dow Jones falling 1.23%, signaling a cautious market mood. Beneath that calm surface, however, sector rotations have been severe: laboratory analytical instruments surged 23.5%, while precious metals and mining stocks took substantial hits, with precious metals down 21.1% and metal mining off 20.0%. The divergence underscores how differently market segments are behaving even in a down-day environment.

Biotechnology and lab equipment were the day's clear winners. Nautilus Biotechnology (NAUT) led all gainers with a +24.6% jump, while Enovix (ENVX) and ArriVent BioPharma (AVBP) each posted 9.4% gains. The Biotechnology: Laboratory Analytical Instruments category averaged +23.5% across 11 companies, including heavyweight names like Agilent Technologies, Waters Corp, and Mettler Toledo. That cohort's strength suggests renewed confidence in diagnostic and measurement tools—possibly tied to pharmaceutical R&D cycles or quality-control demand. Garments and Clothing also performed well, rising 15.2% across five companies including Cintas and VF Corp, hinting at strength in workwear and supply chains serving that segment.

On the flip side, mining and metals got hammered. Precious metals fell 21.1%, with major producers like Newmont, Royal Gold, and Coeur Mining all in the red. Metal mining broadly dropped 20.0%, dragging names like Southern Copper, Freeport-McMoran, and Cleveland-Cliffs lower. The single worst performer, enCore Energy (Other Metals and Minerals), plunged 38.0%. Separately, MacroGenics (MGNX) led all losers with a -38.0% decline, followed by Perspective Therapeutics (CATX) at -28.8%, suggesting individual company troubles rather than sector-wide pressure in those cases.

Staffing-focused Robert Half (RHI) gained 21.7%, possibly reflecting optimism around employment or corporate restructuring activity. Conduent (CNDT) and reAlpha Tech (AIRE) also delivered double-digit gains, though without additional context, isolated single-day moves can reverse quickly.

On the regulatory front, several companies filed their fiscal 2026 annual reports (10-Ks) this week. Commercial Metals (CMC) posted a Health Score of 72.2—solidly in the upper range—while Acuity (AYI), MSC Industrial Direct (MSM), and FactSet Research (FDS) all filed with Health Scores in the 60–61 range. Winnebago Industries (WGO) came in at 60.1. Notably, Micron Technology (MU) filed with a Health Score of just 31.6, well below our typical value-quality threshold, despite the broad semiconductor industry context. Additionally, five companies—Entrada Therapeutics, FS KKR Capital, Bain Capital Specialty Finance, New Mountain Finance, and Innovative Industrial Properties—currently carry audit going-concern flags, meaning auditors have expressed substantial doubt about their ability to continue operating. Investors tracking these names should review the full filing details.

Today's action illustrates a market sorting between growth areas (biotech equipment, apparel supply chains) and cyclical weakness (commodities, mining). For Money Checkup subscribers, this is a reminder to cross-reference individual stock moves with sector tailwinds or headwinds and to review Health Scores and audit flags before making any position decisions—especially when a company files a new 10-K or carries a going-concern note.